These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2995014

  • 1. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).
    Shiraki M, Orimo H, Ito H, Akiguchi I, Nakao J, Takahashi R, Ishizuka S.
    Endocrinol Jpn; 1985 Apr; 32(2):305-15. PubMed ID: 2995014
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. [The effect of 1,25(OH)2D3 on bone mineral content in senile osteoporosis--a dose-finding study].
    Shiraki M, Ito H, Orimo H.
    Nihon Naibunpi Gakkai Zasshi; 1989 Nov 20; 65(11):1253-63. PubMed ID: 2591609
    [Abstract] [Full Text] [Related]

  • 4. Treatment of secondary hyperparathyroidism with intermittent oral high doses of 1-alpha-OHD3 plus pharmacological dose of 24,25(OH)2D3.
    Djukanović L, Pejanović S, Dragojlović Z, Stosović M.
    Ren Fail; 1994 Nov 20; 16(6):715-23. PubMed ID: 7899583
    [Abstract] [Full Text] [Related]

  • 5. Circulating 1,25-dihydroxycholecalciferol after intravenous injections of 1 alpha-hydroxycholecalciferol in patients on regular haemodialysis.
    Papapoulos SE, vd Berg H, Frölich M, Valentijn RM.
    Nephrol Dial Transplant; 1988 Nov 20; 3(5):647-50. PubMed ID: 3146722
    [Abstract] [Full Text] [Related]

  • 6. Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat.
    Hughes MR, Baylink DJ, Gonnerman WA, Toverud SU, Ramp WK, Haussler MR.
    Endocrinology; 1977 Mar 20; 100(3):799-806. PubMed ID: 233823
    [Abstract] [Full Text] [Related]

  • 7. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Mar 20; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 8. Comparative therapeutic effects of vitamin D3 and its derivatives on experimental renal osteodystrophy.
    Fukushima M, Niki R, Ohkawa H, Shimizu T, Matsunaga I, Nakano H, Takagaki Y, Nishii Y, Okano K, Suda T.
    Endocrinology; 1980 Jul 20; 107(1):328-33. PubMed ID: 6247140
    [Abstract] [Full Text] [Related]

  • 9. [The effect of estrogen and, sex-steroids and thyroid hormone preparation on bone mineral density in senile osteoporosis--a comparative study of the effect of 1 alpha-hydroxycholecalciferol (1 alpha-OHD3) on senile osteoporosis].
    Shiraki M, Orimo H.
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb 20; 67(2):84-95. PubMed ID: 1645679
    [Abstract] [Full Text] [Related]

  • 10. Acute effect of oral, intraperitoneal, and intravenous 1 alpha-hydroxycholecalciferol on markers of bone metabolism.
    Joffe P, Ladefoged SD, Cintin C, Jensen LT, Hyldstrup L.
    Nephrol Dial Transplant; 1994 Feb 20; 9(5):524-31. PubMed ID: 8090332
    [Abstract] [Full Text] [Related]

  • 11. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
    Berl T, Berns AS, Huffer WE, Alfrey AC, Arnaud CD, Schrier RR.
    Contrib Nephrol; 1980 Feb 20; 18():72-81. PubMed ID: 6243528
    [Abstract] [Full Text] [Related]

  • 12. Studies on the efficacy of cholecalciferol and derivatives for stimulating phytate utilization in broilers.
    Edwards HM.
    Poult Sci; 2002 Jul 20; 81(7):1026-31. PubMed ID: 12162340
    [Abstract] [Full Text] [Related]

  • 13. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.
    Brandi L, Daugaard H, Tvedegaard E, Storm T, Olgaard K.
    Nephron; 1989 Jul 20; 53(3):194-200. PubMed ID: 2797340
    [Abstract] [Full Text] [Related]

  • 14. Immobilization osteoporosis and active vitamin D: effect of active vitamin D analogs on the development of immobilization osteoporosis in rats.
    Izawa Y, Makita T, Hino S, Hashimoto Y, Kushida K, Inoue T, Orimo H.
    Calcif Tissue Int; 1981 Jul 20; 33(6):623-30. PubMed ID: 6799174
    [Abstract] [Full Text] [Related]

  • 15. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gautvik KM, Gordeladze JO.
    Biosci Rep; 1993 Feb 20; 13(1):27-39. PubMed ID: 8392394
    [Abstract] [Full Text] [Related]

  • 16. Binding properties of plasma vitamin D-binding protein and intestinal 1,25-dihydroxyvitamin D3 receptor in piglets with pseudo-vitamin D-deficiency rickets, type I: treatment effects with pharmacological doses of vitamin D3.
    Kaune R, Schroeder B, Harmeyer J.
    Arch Biochem Biophys; 1990 Nov 01; 282(2):326-32. PubMed ID: 2173481
    [Abstract] [Full Text] [Related]

  • 17. A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure.
    Christiansen C, Rødbro P, Naestoft J, Christensen MS.
    Clin Endocrinol (Oxf); 1981 Sep 01; 15(3):237-42. PubMed ID: 6273028
    [Abstract] [Full Text] [Related]

  • 18. The effect of different vitamin D treatments on serum vitamin D levels in early postmenopausal women.
    Riis B, Christiansen C, Rodbro P.
    Acta Vitaminol Enzymol; 1984 Sep 01; 6(2):77-82. PubMed ID: 6093487
    [Abstract] [Full Text] [Related]

  • 19. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
    Berl T, Berns AS, Hufer WE, Hammill K, Alfrey AC, Arnaud CD, Schrier RW.
    Ann Intern Med; 1978 Jun 01; 88(6):774-80. PubMed ID: 208439
    [Abstract] [Full Text] [Related]

  • 20. Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium.
    Chalkley SR, Richmond J, Barltrop D.
    Occup Environ Med; 1998 Jul 01; 55(7):446-52. PubMed ID: 9816377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.